UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000061267 |
|---|---|
| Receipt number | R000069951 |
| Scientific Title | A Study on Educational Interventions for Frailty Prevention Targeting Community Pharmacists |
| Date of disclosure of the study information | 2026/04/15 |
| Last modified on | 2026/04/15 11:16:25 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A Study on Educational Interventions for Frailty Prevention Targeting Community Pharmacists
Acronym
A Study on Educational Interventions for Frailty Prevention Targeting Community Pharmacists
Scientific Title
A Study on Educational Interventions for Frailty Prevention Targeting Community Pharmacists
Scientific Title:Acronym
A Study on Educational Interventions for Frailty Prevention Targeting Community Pharmacists
Region
| Japan |
Condition
Condition
Frailty, Oral frailty
Classification by specialty
| Geriatrics | Rehabilitation medicine | Dental medicine |
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to implement an e-learning program on frailty prevention for community pharmacists and to evaluate its effects on their knowledge, awareness, and behavioral changes regarding frailty and oral frailty prevention.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Participants in the pharmacist intervention group: Level of understanding regarding frailty and oral frailty; perceived need for measures in the pharmacy and self-efficacy; level of understanding regarding safe pharmacotherapy for older adults; the number of times information was provided to multidisciplinary teams
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Cluster
Blinding
Single blind -participants are blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Behavior,custom |
Interventions/Control_1
Study participants will take part in an educational program on frailty and oral frailty prevention (comprising e-learning, case sharing, and approximately 25 sessions of 10-minute lectures).
Interventions/Control_2
The control group does not participate in the educational program on frailty and oral frailty prevention.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 24 | years-old | <= |
Age-upper limit
| 75 | years-old | > |
Gender
Male and Female
Key inclusion criteria
The study population consists of pharmacists employed at Welcia Pharmacies. The inclusion criteria are: (1) aged 24 years or older but under 75 years, and (2) individuals who have provided informed consent for the study.
Key exclusion criteria
The exclusion criteria are: (1) age 75 or older, and (2) inability to provide informed consent for the study.
Target sample size
750
Research contact person
Name of lead principal investigator
| 1st name | Katsuya |
| Middle name | |
| Last name | Iijima |
Organization
The University of Tokyo
Division name
Institute of Gerontology
Zip code
113-8656
Address
Room 706, Building 8, Faculty of Engineering, 7-3-1 Hongo, Bunkyo-ku, Tokyo
TEL
0358411661
iijima@iog.u-tokyo.ac.jp
Public contact
Name of contact person
| 1st name | Tomoki |
| Middle name | |
| Last name | Tanaka |
Organization
The University of Tokyo
Division name
Institute of Gerontology
Zip code
113-8656
Address
Room 709, Building 8, Faculty of Engineering, 7-3-1 Hongo, Bunkyo-ku, Tokyo
TEL
08041837022
Homepage URL
tmk-tanaka@iog.u-tokyo.ac.jp
Sponsor or person
Institute
The University of Tokyo
Institute
Department
Personal name
Funding Source
Organization
Aeon Co., Ltd. Joint Research Grant
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The University of Tokyo
Address
7-3-1 Hongo, Bunkyo Ward, Tokyo
Tel
-
lifescience.adm@gs.mail.u-tokyo.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 04 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2026 | Year | 03 | Month | 01 | Day |
Date of IRB
| 2025 | Year | 09 | Month | 30 | Day |
Anticipated trial start date
| 2026 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2026 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 04 | Month | 15 | Day |
Last modified on
| 2026 | Year | 04 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069951
